Search uses Goglides API results from the projection-backed discovery index. Private, draft, hidden, unpublished, and admin-only content stays out of public results.
Signed-in searches appear here after you use search.
Tag facets appear after tag usage counts are rebuilt.
Showing public results only.
Zeta reported 50% Q1 revenue growth, raised 2026 guidance again, and launched Athena by Zeta. The proof gate is organic growth, super-scaled customers, adjusted EBITDA margin, and free cash flow.
OpenQ1 2026 revenue beat, raised revenue guidance, and the first sixth-generation 256-qubit system sale. The proof gate is RPO conversion, organic revenue growth, and adjusted EBITDA loss discipline.
OpenAI data centers need power and cooling before they need another software demo.
OpenRevvity is trying to prove the post-spin model can protect margins while faster life-science competitors chase growth.
OpenRedwire has fresh space and drone headlines, but the real RDW proof gate is whether record backlog converts into profitable revenue and cash without new dilution pressure.
OpenSmall modular reactors sound like a data-center power answer, but NuScale still has to prove commercialization.
OpenThermo Fisher and Agilent both use service ecosystems, but capital allocation decides which model compounds better.
OpenD-Wave has one of the clearest customer-demand signals in quantum after record bookings, but the Q1 revenue base remained small and losses expanded.
OpenJoby needs certification progress to arrive before liquidity concerns dominate the air-taxi story.
OpenJoby has an ambitious air-taxi network vision, but the financial runway comes before scale.
OpenIonQ needs to prove its quantum advantage can survive competition from larger tech platforms with deeper budgets.
OpenIonQ benefits from quantum-computing excitement, but investors need to separate scientific progress from commercial revenue.
OpenInfleqtion has a clean quantum identity, record Q1 revenue, and a proposed $100M federal tailwind, but the business still needs revenue scale and operating-loss discipline.
OpenHims is using GLP-1 weight loss to expand the platform, but the quality test is retention and cash flow.
OpenCoherent sits in lasers, optics, and networking components that matter as data traffic explodes.
OpenGinkgo has moved from broad synthetic-biology promise toward a harder profitability test.
OpenDanaher and Agilent both sell into durable lab workflows, but the winner depends on recurring mix, margin quality, and cash conversion.
OpenBitMine priced an upsized preferred-stock deal, and the real question is whether ETH treasury growth can beat a new preferred dividend claim that sits ahead of common shareholders.
OpenBMNR said crypto plus cash plus other holdings totaled twelve point three billion dollars as of May 25, 2026. The proof gate is ETH per share, staking yield, cash runway, and NAV transparency.
OpenBio-Rad has diagnostics exposure, but the market may be questioning whether the segment deserves a peer-growth multiple.
Open